Niramai’s patented product Thermalytix uses Artificial Intelligence (AI) and a high-resolution thermal sensing device, and is a portable, non-invasive, radiation-free, and non-contact solution that measures the temperature of the chest region to detect early-stage breast cancer accurately. It is safe, privacy-aware, portable, and enables detection of early-stage malignancy. The end-to-end solution includes off-the-shelf hardware, Niramai’s own software, training, auto- generation, and certification of reports, support, and maintenance. The startup provides complete hardware-software solution for breast cancer screening in three modes i.e.(a) Sturdy, compact screening device with cloud processing for specialty hospitals (b) Low-cost, handheld device with real-time cloud-based diagnostics for independent medical practitioners (c) A portable solution for large-scale screenings.